drugset / Trial / NCT00641927
Antidepressant Therapy for Bipolar II Major Depression
RandomizedParallel-groupOpen-labelTreatment
Summary
This study examines the relative safety and benefit of antidepressant therapy (versus recommended mood stabilizer therapy)of bipolar type II major depressive episode. We hypothesize that antidepressant therapy will be superior to mood stabilizer therapy with little or no difference in treatment emergent manic symptoms.
Timeline
- Start
- 2002-04
- Primary completion
- 2006-10
- Completion
- 2006-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Lithium Carbonate | Unknown | 300 mg | — |
| Comparator | Lithium Carbonate | Unknown | 2100 mg | — |
| Subject | Venlafaxine | Small molecule | 37.5 mg | — |
| Subject | Venlafaxine | Small molecule | 375 mg | — |